Details
Cardiodaron Indications
Prevention of relapse:
- Ventricular tachycardia, which is a threat to the life of the patient, the treatment should be started in the hospital in the presence of a constant monitoring of the patient;
- Symptomatic ventricular tachycardia (documented) that leads to disability;
- Supraventricular tachycardia (documented) that requires treatment, and in cases where other drugs have no therapeutic effect or are contraindicated;
- Ventricular fibrillation.
Treatment of supraventricular tachycardia: slowing down or reducing atrial fibrillation or flutter.
Coronary heart disease and / or dysfunction of the left ventricle.
Contraindications
Sinus bradycardia, sinoatrial heart block in the absence of endocardial pacemaker (artificial pacemaker), sinus syndrome without endocardial pacemaker (risk stop sinus), violations of atrioventricular conduction high level in the absence of endocardial pacemaker thyroid dysfunction, known hypersensitivity to iodine, amiodarone or one of the excipients; in combination with drugs that may induce the occurrence piruetnoyi ventricular tachycardia (torsades de pointes): antiarrhythmic drugs Ia class (quinidine, hidrohinidyn, dyzopiramid), antiarrhythmic drugs class III (sotalol, dofetilide, ibutylid), other drugs (compounds mouse ' which, bepridil, cisapride, dyfemanil, dolasetron intravenously, some neuroleptic agents (see. section "Interaction with other medicinal products and other forms of interaction"), erythromycin IV, pentamidine (for parenteral administration) mizolastyn, vinkamitsyn intravenous moxifloxacin, spiramycin IV , toremifene.
Dosage & Administration
Assign an adult inside, during or after meals, not liquid, squeezed small amount of liquid.
The initial treatment. Typically, the recommended dose for adults is 200 mg (1 tablet) 3 times daily for 8-10 days.
In some cases, early treatment can use higher doses (4-5 tablets per day), which take a short period of time and under the control of ECG.
Supportive treatment. It is necessary to apply the minimum effective dose. Depending on the therapeutic efficacy of each individual patient maintenance dose for adults ranges from ½ tablet a day (or 1 tablet every two days) to 2 tablets per day.
